Multiple levels of MHC class I down-regulation by ras oncogenes

Scandinavian Journal of Immunology

Volumn 43, Issue 5, 1996, Pages 537-544

  Lohmann, S ^a   Wollscheid, U ^a   Huber, C ^a   Seliger, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ANIMAL CELL; ARTICLE; DOWN REGULATION; H2 SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL;

EID: 0029886683     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-73.x     Document Type: Article

References (41)

1. Zinkernagel KB, Doherty PC. MHC restricted cytotoxic T-cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity. Adv Immunol 1979;27:51-77.
2. Festenstein KB, Garrido F. MHC antigens and malignancy. Nature 1986;322:502-3.
3. Goodenow RS, Vogel JM, Linsk RL. Histocompatibility antigens on murine tumors. Science 1985;230:777-83.
4. Plata F, Tilkin AF, Levy JP et al. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytotoxic T-lymphocytes. J Exp Med 1981;184:1795-810.
5. Hämmerling GJ, Klar D, Pulm W et al. The influence of MHC class I antigens on tumor growth and metastasis. Biochim Biophys Acta 1987;179:245-59.
6. Seliger B, Harders C, Wollscheid U et al. Suppression of MHC class I antigens in oncogenic transformants: Association with decreased recognition by cytotoxic T lymphocytes., in press, Exp Hematology.
7. Schrier PI, Bernards R, Vaessen RMMJ et al. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 1983;305:771-6.
8. Eager K, Williams J, Breiding D et al. Expression of histocompatibility antigens H-2K, -D and L is reduced in adenovirus 12 transformed mouse cells and is restored by IFN. Proc Natl Acad Sci USA 1985;82:5525-9.
9. Mausdley DJ, Pond JS. Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today 1991;12:429-31.
10. Schrier PI, Peltenburg LTC. Relationship between myc oncogene activation and MHC class I expression. Adv Cancer Res 1993;60: 181-246.
11. Seliger B, Lohmann S, Huber C et al. Regulation of major histocompatibility complex class I gene expression in oncogene-transformed mouse fibroblasts. In: Bergmann, L, Mitrou, PS, eds. Cytokines in Cancer Therapy. Karger Verlag, 1994: 11-23.
12. Ackrill AM, Blair E. Regulation of major histocompatibility class I antigen expression at the level of transcription in highly oncogenic adenovirus transformed rat cells. Oncogene 1988;3:483-7.
13. Lassam N, Jay G. Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation. J Immunol 1989;143:3792-7.
14. Ting JP, Baldwin AS. Regulation of MHC gene expression. Curr Opin Immunol 1993;5:8-16.
15. Seliger B, Pfizenmaier K. Post-transcriptional down-regulation of MHC class I expression in oncogene-transformed cells is reverted by IFN-alpha and -gamma. J Immunogenet 1989;16:315-20.
16. Vaessen RTMJ, Houweling A, Van der Eb J. Posttranscriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 1987;235:1486-8.
17. Shemesh J, Rotem-Yeduhar R, Ehrlich R. Transcriptional and posttranscriptional regulation of class I major histopcompatibility complex genes following infection and transformation with human adenoviruses. J Virol 1991;65:5544-8.
18. Cromme FV, Airey J, Heemels MT et al. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 1994;179:335-40.
19. Restifo NP, Esquivel F, Kawakami Y et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72.
20. Rotem-Yeduhar R, Winograd S, Sela S et al. Down-regulation of peptide transporter genes in cell lines transformed with highly oncogenic adenovirus 12. J Exp Med 1994;180:477-88.
21. Seliger B, Kruppa G, Pfizenmaier K. Murine interferon-gamma inhibits v-mos-induced transformation via down-regulation of retroviral gene expression. J Virol 1988;61:2567-72.
22. Seliger B, Pfizenmaier K, Schäfer R. Short term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts. J Virol 1991;65:6307-11.
23. Jaggi R, Salmons B, Muellener D et al. The v-mos and H-ras oncgene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR. EMBO J 1986;5:2609-16.
24. Rahmsdorf HJ, Schönthal A, Angel P et al. Posttranscriptional regulation of c-fos mRNA expression. Nucl Acids Res 1987;15:1643-59.
25. Chirgwin JM, Przybyla AA, MacDonald RJ et al. Isolation of biological active ribonucleic acid from sources enriched in ribonuclease. Biochem 1979;18:5294-9.
26. Feinberg AP, Vogelstein B. Technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
27. d histocompatibility antigen. Nucl Acids Res 1983;11:1567-77.
28. 2-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNAs. Proc Natl Acad Sci USA 1981;78:2253-9.
29. Ellis DW, DeFeo D, Shin TY et al. The p. 21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 1981;292:506-9.
30. Cleveland DW, Lopata MA, MacDonald RJ et al. Number and evolutionary conservation of alpha and beta tubulin and cytoplasmic beta and gamma actin genes using specific cloned cDNA probes. Cell 1981;20:95-105.
31. Graham KL, Van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virol 1973;52:456-67.
32. b promoter: Enhancer-like sequences and their role in the regulation of class 1 gene expression. Cell 1988;44:261-72.
33. De la Luna S, Soria I, Pulido D et al. Efficient transformation of mammalian cells with constructs containing a puromycin resistance marker. Gene 1988;62:121-6.
34. Seliger B, Stark G, Pfizenmaier K. Tumor necrosis factor-alpha affects LTR-controlled oncogene expression in transformed mouse fibroblasts at the posttranscriptional level. J Immunol 1988;141:2138-44.
35. Versteeg R, Krüse-Wolters KM, Plomp A et al. Suppression of class I major histocompatibilty leukocyte antigen by c-myc is locus-specific. J Exp Med 1989;170:621-35.
36. Garrido F, Cabrera T, Concha A et al. Natural history of HLA expression during tumour development. Immunol Today 1993;14:491-9.
37. Momburg F, Ziegler A, Harprecht J et al. Selective loss of HLA-A and -B antigen expression in colon carcinoma. J Immunol 1989;142:352-8.
38. Vegh Z, Wang P, Wanky F et al. Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors. Cancer Res 1993;53:2416-20.
39. 2 m gene expression. J Clin Invest 1991;87:284-92.
40. 2-microglobulin and cell surface expression. Differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 1988;18:801-10.
41. Trowsdale J, Hanson I, Mockridge I et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990;348:741-3.